Global Dravet Syndrome Market

Global Dravet Syndrome Market Size, Share, Growth Analysis, By Diagnosis(MRI, EEG), By Treatment and Management(Seizure medications, A ketogenic diet), By Type(Pharmaceutical Companies, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35A2815 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 92 | Figures: 67

Global Dravet Syndrome Market Insights

Global Dravet Syndrome Market size was valued at USD 343.85 million in 2022 and is poised to grow from USD 376.17 million in 2023 to USD 771.84 million by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

Dravet’s syndrome, also known as epilepsy, typically presents with recurrent seizures triggered by fever or high temperature. This rare neurological disorder is usually lifelong, affecting individuals from childhood. Dravet syndrome begins in the first year of life and is initially diagnosed in otherwise healthy infants. As the disorder progresses, seizures develop, leading to complications and challenges associated with managing this condition. The unique nature of Dravet syndrome underscores the importance of specialist care and ongoing support for affected individuals and their families.

Market snapshot - 2024-2031

Global Market Size

USD 343.85 million

Largest Segment

MRI

Fastest Growth

MRI

Growth Rate

9.4% CAGR

Global Dravet Syndrome Market ($ Mn)
Country Share for North america Region (%)
Global Dravet Syndrome Market By Diagnosis ($ Mn)
Global Dravet Syndrome Market By Diagnosis (%)

To get more reports on the above market click here to Buy The Report

Global Dravet Syndrome Market Segmental Analysis

Based on Diagnosis, the global Dravet Syndrome industry has been segmented by MRI, EEG, and SCN1A testing. Based on Treatment and Management, the Dravet Syndrome Market segmentation includes seizure medications, a ketogenic diet, and vagus nerve stimulation. The Dravet Syndrome Market segmentation is based on the type of seizures, myoclonic, partial, and absence seizures. End-user has bifurcated the Dravet Syndrome Market data into Pharmaceutical Companies, Hospitals, Diagnostic Laboratories, Academic & research institutes And Others. By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World.

Analysis by Diagnosis

By 2022, MRI (Magnetic Resonance Imaging) segment will emerge as the dominant player, commanding a major share in the Dravet syndrome surgical products market. This could be attributed to the rapid integration of state-of-the-art surgical products for Dravet syndrome. A collection of experienced medical professionals MRI market research is experiencing phenomenal growth driven by technological advancements, with innovations such as open MRI, visualization software and superconducting magnets contributing to its expansion.

Electroencephalography (EEG) plays an important role in the Dravet Syndrome market as an important diagnostic tool and a means of monitoring individuals severely affected by this epilepsy. EEG helps to identify and characterize the unique seizure patterns associated with Dravet syndrome, which helps to accurately diagnose Continuous or intermittent EEG monitoring is often used to assess seizure frequency and severity, and provide valuable insight into how for healthcare professionals.

Analysis by End-User

The hospital segment has emerged as the dominant force in the market by 2022 and is expected to maintain its rapid growth trajectory throughout the forecast period from 2024 to 2031. This dominance can be attributed to patients well equipped, heavily treated in hospital settings with their modern facilities and ample facilities. Most individuals seeking treatment, especially individuals with complex conditions, are encountered in the hospital setting.

Pharmaceutical companies play an important role in the Dravet syndrome market by actively supporting research, development and treatment solutions for individuals affected by this rare neurological disorder These companies owe significant investments are made in new drugs and treatments aimed at addressing the complex complications associated with Dravet syndrome . Their involvement includes the full spectrum of drug development from preclinical research to clinical trials to regulatory approval. In addition, pharmaceutical companies manufacture and distribute approved drugs, making them available to patients in need.

Global Dravet Syndrome Market By Diagnosis, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Dravet Syndrome Market Regional Insights

Market trends for specific industries highlight North America as the dominant region, exhibiting the greatest impact, followed by Europe and Asia Pacific Key market players are actively directing their efforts towards developing new drugs and therapies development, using various strategies to strengthen their market position. The competitive environment is characterized by a proactive approach in leading organizations, which engage in ongoing R&D activities to come up with innovative solutions. These strategic initiatives not only contribute to the expansion of the market but also enhance the competitive edge of the major competitors.

Asia Pacific is poised for rapid growth in Dravet syndrome market, driven by increasing incidence of diseases, increasing patient survival rates and expanding range of treatment modalities Countries such as India, China and South Korea are actively deploying R&D initiatives priority, Furthermore, these countries are undergoing major healthcare reforms aimed at increasing the availability, affordability and quality of healthcare Notably, China and India are reforming comprehensive to address health challenges and improve overall health care.

Global Dravet Syndrome Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Dravet Syndrome Market Dynamics

Drivers

Increasing Heightened Occurrence of Gene Mutations

  • Genetic mutations, especially SCN1A gene mutations, contribute significantly to the onset of Dravet syndrome in children, with approximately 80-90% of cases associated with mutations in this gene in this tissue specifically this related Advancement in genetic testing technology is expected to drive market revenue growth of testing methods. If applied, such as dual detection, deletion, mosaicism, and other methods a sophisticated diagnostic approach will play an important role in the accurate and efficient diagnosis of genetic abnormalities associated with Dravet syndrome.

Restraints

Potential Impediments

  • The anticipated revenue generation of Dravet Syndrome faces potential obstacles for a variety of reasons. Historically, epilepsy and related seizure disorders have been shrouded in societal stigma, discrimination, misinformation, and fear across many regions globally. The pervasive stigma associated with the ailment could act as a deterrent for individuals seeking treatment, as the fear of being identified with such a condition may discourage them from seeking the necessary medical care.

Request Free Customization of this report to help us to meet your business objectives.

Global Dravet Syndrome Market Competitive Landscape

The competitive environment of the global Dravet Syndrome market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.

Top Player’s Company Profiles

  • SK Biopharmaceuticals
  • Biocodx
  • Upsher Smith Laboratories, LLC.
  • Encoded Therapeutics Inc.
  • GW Research Ltd.
  • UCB S.A.
  • Zogenix
  • Supernus Pharmaceuticals
  • Epygenix Therapeutics, Inc.,
  • Ovid Therapeutics Inc.
  • Takeda Pharmaceutical Company Limited.

Recent Developments

  • In February 2024, Encoded Therapeutics Inc., a biotech firm dedicated to genetic medicines targeting severe central nervous system (CNS) disorders, revealed the global development plan for its primary gene therapy candidate, ETX101, aiming to address SCN1A+ Dravet syndrome. Dravet syndrome, the most prevalent form of developmental and epileptic encephalopathy, presents a range of clinical manifestations, such as intractable seizures and neurodevelopmental regression. 
  • In November 2023, Health Canada greenlights Epidiolex (cannabidiol) for treating seizures in Dravet syndrome, broadening its accessibility for this epilepsy form. Developed by GW Pharmaceuticals (now Jazz Pharmaceuticals), the oral solution gains approval for Lennox-Gastaut syndrome (LGS) and tuberous sclerosis complex (TSC) as well, marking progress in addressing various seizure types.

Global Dravet Syndrome Key Market Trends

  • Recent developments in regulatory approvals have played an important role in driving the Dravet Syndrome project forward. Notably, withdrawal from medications such as stiripentol (Diacomit) and Epidiolex have been extremely helpful in managing and treating the symptoms associated with the disorder. These regulatory veins mark important points landmark in dealing with the severe complications of Dravet syndrome. Furthermore, expectations of upcoming regulatory approvals, exemplified by Zogenix’s New Drug Application (NDA) submission for its clinical candidate ZX008 (Fintepla), are expected to fuel the rapid expansion of the market.

Global Dravet Syndrome Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. Dravet Syndrome, also recognized as Severe Myoclonic Epilepsy of Infancy (SMEI), stands as a rare genetic disorder that affects about one in every 15,700 people worldwide It usually appears during infancy, and infants are prone to prolonged and difficult-to-control seizures. As a child advances in age, the frequency and severity of seizures may increase, possibly leading to psychosocial complications and although the prevalence of Dravet syndrome lies region although it is estimated to affect about one in every 20,000 to 40,000 people worldwide Comparatively, it is more common in men, with a male-to-female ratio of about 1.5:1 These findings highlight the rare and sex-specific differences associated with Dravet syndrome, and emphasize the need for specialized monitoring and management of affected individuals.

Report Metric Details
Market size value in 2023 USD 343.85 million
Market size value in 2031 USD 771.84 million
Growth Rate 9.4%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Diagnosis
    • MRI, EEG, and SCN1A testing
  • Treatment and Management
    • Seizure medications, A ketogenic diet, and Vagus nerve stimulation
  • Type
    • Pharmaceutical Companies, Hospitals, Diagnostic Laboratories, Academic & research institutes, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • SK Biopharmaceuticals
  • Biocodx
  • Upsher Smith Laboratories, LLC.
  • Encoded Therapeutics Inc.
  • GW Research Ltd.
  • UCB S.A.
  • Zogenix
  • Supernus Pharmaceuticals
  • Epygenix Therapeutics, Inc.,
  • Ovid Therapeutics Inc.
  • Takeda Pharmaceutical Company Limited.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Dravet Syndrome Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Dravet Syndrome Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Dravet Syndrome Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Dravet Syndrome Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Dravet Syndrome Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Dravet Syndrome Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Dravet Syndrome Market size was valued at USD 343.85 million in 2022 and is poised to grow from USD 376.17 million in 2023 to USD 771.84 million by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The competitive environment of the global Dravet Syndrome market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'SK Biopharmaceuticals', 'Biocodx', 'Upsher Smith Laboratories, LLC.', 'Encoded Therapeutics Inc.', 'GW Research Ltd.', 'UCB S.A.', 'Zogenix', 'Supernus Pharmaceuticals', 'Epygenix Therapeutics, Inc.,', 'Ovid Therapeutics Inc.', 'Takeda Pharmaceutical Company Limited.'

Genetic mutations, especially SCN1A gene mutations, contribute significantly to the onset of Dravet syndrome in children, with approximately 80-90% of cases associated with mutations in this gene in this tissue specifically this related Advancement in genetic testing technology is expected to drive market revenue growth of testing methods. If applied, such as dual detection, deletion, mosaicism, and other methods a sophisticated diagnostic approach will play an important role in the accurate and efficient diagnosis of genetic abnormalities associated with Dravet syndrome.

Recent developments in regulatory approvals have played an important role in driving the Dravet Syndrome project forward. Notably, withdrawal from medications such as stiripentol (Diacomit) and Epidiolex have been extremely helpful in managing and treating the symptoms associated with the disorder. These regulatory veins mark important points landmark in dealing with the severe complications of Dravet syndrome. Furthermore, expectations of upcoming regulatory approvals, exemplified by Zogenix’s New Drug Application (NDA) submission for its clinical candidate ZX008 (Fintepla), are expected to fuel the rapid expansion of the market.

Market trends for specific industries highlight North America as the dominant region, exhibiting the greatest impact, followed by Europe and Asia Pacific Key market players are actively directing their efforts towards developing new drugs and therapies development, using various strategies to strengthen their market position. The competitive environment is characterized by a proactive approach in leading organizations, which engage in ongoing R&D activities to come up with innovative solutions. These strategic initiatives not only contribute to the expansion of the market but also enhance the competitive edge of the major competitors.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Dravet Syndrome Market

Product ID: SQMIG35A2815

$5,300
BUY NOW GET FREE SAMPLE